These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6299092)

  • 61. [Cancer, hemostasis and coaguloactive drugs].
    Nadiradze ISh
    Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
    [No Abstract]   [Full Text] [Related]  

  • 62. Thrombopoietin: biology and potential clinical applications.
    Prow D; Vadhan-Raj S
    Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro evaluation of anticancer drugs with the human tumor stem cell assay.
    Salmon SE; Von Hoff DD
    Semin Oncol; 1981 Dec; 8(4):377-85. PubMed ID: 6275552
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
    Wood S
    J Med; 1974; 5(1):7-22. PubMed ID: 4134042
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of suramin on anastomotic colon tumors in a rat model.
    Lauwers P; Hubens G; Hendriks J; Vermeulen P; Schuerwegh A; Stevens WJ; De Clerck LS; Dirix L; Van Marck E; Hubens A; Eyskens E
    Eur Surg Res; 1999; 31(4):347-56. PubMed ID: 10449994
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts.
    Poirson-Bichat F; Gonçalves RA; Miccoli L; Dutrillaux B; Poupon MF
    Clin Cancer Res; 2000 Feb; 6(2):643-53. PubMed ID: 10690550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.
    De La Cruz JP; Moreno A; Mérida F; García Campos J; Sánchez de la Cuesta F
    Thromb Res; 1996 Feb; 81(3):327-37. PubMed ID: 8928090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Involvement of platelets in tumor cell metastasis.
    Tesfamariam B
    Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antimetastatic agents. II. Summary of the interactions of tumor cells with blood coagulation factors, platelets, fibrinolytic factors, and inflammatory cells and their soluble mediators: potential for therapeutic interventions.
    Rickles FR; Hancock WW
    Semin Thromb Hemost; 1988 Jan; 14(1):126-32. PubMed ID: 3353730
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Blood coagulation changes and pathogenesis of diabetic retinopathy. Recent advances].
    Porta M; Nuzzi R; Passera P
    Minerva Med; 1984 Oct; 75(41):2407-20. PubMed ID: 6390258
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
    Gastpar H
    Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of platelets in vasogenic brain edema. II. Contribution of platelet serotonin in brain edema.
    Segawa H; Patterson RH; Gilder H
    Arch Neurol; 1981 Jun; 38(6):345-9. PubMed ID: 7236061
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Concepts for treatment of micrometastases developed in murine systems.
    Schabel FM
    AJR Am J Roentgenol; 1976 Mar; 126(3):500-11. PubMed ID: 178196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane.
    Menter DG; Sloane BF; Steinert BW; Onoda J; Craig R; Harkins C; Taylor JD; Honn KV
    J Natl Cancer Inst; 1987 Nov; 79(5):1077-90. PubMed ID: 3479634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
    Dawicki DD; Agarwal KC; Parks RE
    Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preliminary report of a cooperative randomized study for the treatment of localized small cell lung carcinoma.
    Seydel HG; Creech RH; Mietlowski WL; Perez CA
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1445-7. PubMed ID: 231592
    [No Abstract]   [Full Text] [Related]  

  • 78. Studies on the vasoocclusive crisis of sickle cell disease. III. In vitro and in vivo effect of the pyrimido-pyrimidine derivative, RA-233: studies on its mechanism of action.
    Ambrus JL; Bannerman RM; Sills RH; Meky N; Sharma S; Stadler S; Gastpar H; Marton J; Melewski DJ
    J Med; 1987; 18(3-4):165-98. PubMed ID: 3480932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The rationale of anticoagulants in the treatment of cancer.
    Cliffton EE; Grossi CE
    J Med; 1974; 5(1):107-13. PubMed ID: 4275504
    [No Abstract]   [Full Text] [Related]  

  • 80. [Cancer blood-borne metastasis and platelets].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.